Skip to main content

Resources

Healthcare Glossary

Explore the key terms of digital health, risk management, NIS2 cybersecurity and technological innovation in medicine.

ACN (Italian National Cybersecurity Agency)

The Agenzia per la Cybersicurezza Nazionale (ACN, the Italian National Cybersecurity Agency) is the Italian authority responsible for cybersecurity, established by Decree-Law no. 82 of 14 June 2021. With Legislative Decree 138/2024, ACN becomes the national authority designated under the NIS2 Directive. ACN manages the registration of essential and important entities, receives notifications of significant incidents (Art. 25), publishes operational guidelines, carries out supervision and inspections and has the power to impose penalties on non-compliant organisations. Dealing with ACN, particularly in the event of an incident, is one of the key competences required of the management and the CISO of NIS2 entities.

Advanced Triage

Advanced triage is an evolved model of initial assessment in emergency care which, in addition to assigning priority, includes structured collection of clinical data and early activation of diagnostic and therapeutic pathways. Compared with traditional triage, advanced triage aims to reduce waiting times and clinically relevant delays, improving the appropriateness and safety of the pathway in the Emergency Department. Its effectiveness depends on clear protocols, dedicated training and integration with clinical information systems.

Annex I and Annex II of Legislative Decree 138/2024

Annexes I and II of Legislative Decree 138/2024 list the sectors of activity and types of service that bring an organisation within NIS2 scope. Annex I — sectors of high criticality — covers energy, transport, banking, financial market infrastructures, health, drinking water and waste water, digital infrastructure, ICT service management (B2B), public administration and space. Annex II — other critical sectors — covers postal services, waste management, chemicals, food, manufacturing (medical devices, computers and electronics, machinery, motor vehicles and other transport equipment), digital providers and scientific research. Correctly identifying whether an organisation falls under one of the Annexes is the first step of the NIS2 gap analysis: together with company size, it determines whether the organisation is out of scope, an important entity or an essential entity.

API (Application Programming Interface)

An API (Application Programming Interface) is a set of rules and protocols that allows different software applications to communicate with one another, making it easier to exchange data and access specific functions. APIs make it possible to integrate different systems: in healthcare, for example, they allow several applications to access the same electronic health record, improving efficiency and continuity of care.

Art. 20 Legislative Decree 138/2024 — Governance and training

Art. 20 of Legislative Decree 138/2024 governs cybersecurity governance in NIS2 entities and introduces two separate obligations. The first concerns the management body (Board of Directors, Chief Executive Officers, senior managers): it must approve the cybersecurity risk management measures adopted by the organisation, oversee their implementation and is personally liable for infringements. This liability is individual and cannot be delegated. The second concerns training: the organisation must ensure regular and adequate cybersecurity training, for both the management and operational staff, in proportion to their role and exposure to risk. The training must be documented and verifiable.

Art. 21 Legislative Decree 138/2024 — Risk management measures

Art. 21 of Legislative Decree 138/2024 lists the minimum technical and organisational measures that NIS2 entities must adopt to manage the risks posed to the security of the network and information systems they use in their activities. The measures include: policies on risk analysis and information system security, incident handling, business continuity (backup, disaster recovery, crisis management), supply chain security, security in the acquisition, development and maintenance of systems, assessment of the effectiveness of risk management measures, basic cyber hygiene and training, cryptography, human resources security, access control and asset management, multi-factor authentication and secured communications. The measures must be proportionate to the risk and documented so that they can be shown in the event of an ACN inspection.

Art. 25 Legislative Decree 138/2024 — Incident notification

Art. 25 of Legislative Decree 138/2024 governs the procedure for notifying significant incidents to the Agenzia per la Cybersicurezza Nazionale (ACN). The procedure has three time-bound steps, all counted from the moment the organisation became aware of the incident: an early warning within 24 hours (indicating whether the incident may be malicious and whether it may have a cross-border impact), a full notification within 72 hours (with an initial assessment, indicators of compromise and the mitigation measures taken or planned) and a final report within one month (analysis of the causes, severity, impact, measures taken and ongoing mitigation measures). Failure to comply, or late compliance, exposes the organisation to the penalties of Art. 38 and may affect the overall assessment of the adequacy of the measures under Art. 21.

Claims Assessment Committee (CVS)

The Comitato Valutazione Sinistri (CVS, Claims Assessment Committee) is a multidisciplinary body that, in healthcare and social care organisations, analyses claims and complaints involving potential professional or organisational liability. The CVS assesses how the event unfolded, its clinical and legal impact, possible causes and corrective measures, supporting clinical risk management and dialogue with insurers, legal departments and the medical directorate. When the CVS works properly, it brings together prevention, litigation management and organisational learning from adverse cases.

Clinical audit

Clinical audit is a systematic process for assessing care practice against explicit, shared standards, with the aim of improving quality, safety and outcomes of care. In healthcare, clinical audit typically follows a continuous cycle: choice of topic, data collection, comparison with standards, analysis of deviations, improvement plan and re-assessment. When well designed, clinical audit supports clinical governance, the reduction of unwarranted variation and the improvement of patient safety.

Essential Entity (NIS2)

An “essential entity” is one of the two categories of organisations within NIS2 scope introduced by Legislative Decree 138/2024. Large companies operating in the highly critical sectors listed in Annex I (energy, transport, banking, financial market infrastructures, health, drinking water, digital infrastructure, ICT service management (B2B), public administration, space) qualify as essential. Essential entities are subject to the strictest supervisory regime: ex ante inspections, security audits, administrative fines of up to 10 million euros or 2% of total worldwide annual turnover (whichever is higher) and personal liability of the management under Art. 38.

FMEA/FMECA

FMEA (Failure Mode and Effects Analysis) and FMECA (Failure Mode, Effects and Criticality Analysis) are proactive risk analysis methodologies used to identify possible failure modes in processes, devices or clinical pathways. FMEA assesses the potential effect of the failure; FMECA adds the dimension of criticality, helping to prioritise interventions according to probability, severity and detectability. In healthcare risk management, FMEA/FMECA make it possible to prevent adverse events before they occur, improving the reliability and safety of clinical and care processes.

HAI (Healthcare-Associated Infections)

HAIs (Healthcare-Associated Infections, ICA in Italian) are infections acquired during the care pathway in hospital, in community facilities or in other care settings, which were neither present nor incubating at the time of admission. HAIs are a significant indicator of the quality and safety of care, with considerable clinical, organisational and economic impacts. Preventing HAIs requires structured infection prevention and control (IPC) programmes: hand hygiene, surveillance, antimicrobial stewardship and continuing staff training.

Important Entity (NIS2)

An “important entity” is the second category of organisations within NIS2 scope. It covers medium-sized companies in the Annex I sectors and organisations (medium-sized and large) in the Annex II sectors of Legislative Decree 138/2024 (postal services, waste management, manufacture, production and distribution of chemicals, production, processing and distribution of food, high-risk manufacturing, digital providers, research). Important entities have the same substantive obligations (Art. 20, 21, 25) but are subject to ex post supervision (only after a report or an incident) and to lower penalties: up to 7 million euros or 1.4% of total worldwide annual turnover.

LASA (Look-Alike/Sound-Alike)

LASA (Look-Alike/Sound-Alike) refers to medicines with similar names or packaging that are easily confused because of their appearance or how they sound. The LASA risk increases the likelihood of errors in prescribing, preparing, dispensing and administering medicines, with potentially serious consequences for patient safety. Prevention strategies include standardisation, Tall Man Lettering, independent double checks and digital decision support in pharmacies and on wards.

Near miss

A near miss is an incident that could have harmed the patient but which, through favourable circumstances or timely interception, had no clinical consequences. Near misses are a valuable source of organisational learning because they reveal process vulnerabilities before they turn into real adverse events. The systematic, non-punitive collection of near misses is a key practice in mature patient safety and clinical risk management systems.

NIS2 (EU Directive 2022/2555)

NIS2 is Directive (EU) 2022/2555 of the European Parliament and of the Council of 14 December 2022, transposed in Italy by Legislative Decree no. 138 of 4 September 2024. It replaces the previous NIS Directive (2016/1148), significantly widening its scope, obligations and penalty regime. NIS2 introduces a distinction between “essential” and “important” entities, based on the sector of activity (Annexes I and II) and the size of the organisation, and imposes obligations on risk management (Art. 21), incident notification (Art. 25) and training and accountability of the management body (Art. 20). For organisations within scope, NIS2 is not a formal exercise: it is an ongoing regime that requires policies, processes, evidence and documented training.

PARM (Annual Risk Management Plan)

The PARM (Piano Annuale di Risk Management, Annual Risk Management Plan) is the planning document in which a healthcare organisation sets out objectives, actions, indicators and responsibilities for clinical risk management over the year. The PARM brings together the analysis of adverse events, safety priorities, staff training, indicator monitoring and the governance of preventive and corrective measures. An effective PARM aligns management, clinical functions and support functions on a measurable path of continuous improvement in patient safety.

Patient Engagement

Patient Engagement is the active involvement of patients in their own care pathway, through informed and collaborative participation with healthcare professionals. Good patient engagement encourages better treatment adherence, helps improve clinical outcomes and, in general, improves the overall experience of care. Digital Patient Engagement (DPE) is a subset of Patient Engagement that considers the use of digital resources in the relationship with the patient.

Patient Experience

Patient Experience (PX) covers all the interactions a patient has with those who care for them, from the individual healthcare professional to the entire health system. All aspects of the relationship matter for Patient Experience: clinical aspects, communication, organisation, etc. Taken as a whole, the experience determines the overall perception of the quality of care received.

PDTA (Integrated Care Pathways)

PDTAs (Percorsi Diagnostico Terapeutici Assistenziali, the Italian integrated diagnostic, therapeutic and care pathways) are a clinical management tool for defining the best care process to meet specific health needs, based on the available scientific evidence on the subject, adapted to the local context and taking into account the available resources. PDTAs make it possible to standardise the therapeutic approach, support a process of improving care and, finally, optimise the use of healthcare resources.

PREM (Patient-Reported Experience Measures)

Patient-Reported Experience Measures (PREMs), i.e. the measurement of experiences reported by patients, are tools – typically validated questionnaires – through which patients describe the care they have experienced: accessibility, communication, empathy, waiting times, coordination between health professionals and other aspects form a set of measures showing how the patient perceived the experience. The focus of PREMs is not so much the clinical outcome as the quality of the interaction and of the organisation along the pathway, from the patient’s point of view.

PROM (Patient-Reported Outcome Measures)

Patient-Reported Outcome Measures (PROMs), i.e. the measurement of outcomes reported by patients, are tools – typically validated questionnaires – through which people directly describe their own health status: symptoms, functioning, quality of life and other aspects. PROMs complement “objective” clinical outcomes with what matters to the patient, making it possible to measure the perceived effectiveness of treatments, procedures and care pathways. Collecting PROMs at set points in time – for example before a procedure and/or 30/60/90/180 days afterwards – or periodically in the case of chronic conditions, makes it possible to compare what is reported over time, in order to improve care pathways and other healthcare experiences.

RCA (Root Cause Analysis)

RCA (Root Cause Analysis) is a structured retrospective analysis methodology used to identify the underlying causes of an adverse event or significant incident. Unlike an approach centred on individual human error, RCA examines system factors: processes, organisation, communication, technology, environment and culture. The aim of RCA is to define sustainable corrective actions that reduce the risk of recurrence and improve the safety of the care pathway.

SaaS (Software as a Service)

SaaS is a service model in which software, typically accessed remotely, is paid for according to how it is used and the agreements with the supplier. Thanks to the SaaS service model, upfront costs and infrastructure costs are reduced considerably. In addition, software made available as SaaS is typically cloud-based and accessible at any time and from any device.

Sentinel events

Sentinel events are particularly serious, potentially avoidable adverse events that signal a serious malfunction in the care system and require immediate analysis. In healthcare, sentinel events may include, for example, errors in the operating theatre, serious falls, suicides of inpatients or other events with a severe outcome for the patient. Reporting sentinel events and analysing them in a structured way are central to patient safety and to preventing recurrence through measurable corrective actions.

Significant incident (NIS2)

Legislative Decree 138/2024 (Art. 25) defines a “significant incident” as an incident that has caused or is capable of causing severe operational disruption of the services or financial loss for the entity concerned, or that has affected or is capable of affecting other natural or legal persons by causing considerable material or non-material damage. Classification as “significant” is subject to thresholds and operational criteria that ACN has published in specific guidelines (ACN Determinations). It is this classification that triggers the 24h / 72h / 1 month notification procedure and therefore the obligation to engage with ACN. The organisation must be able to detect, classify and qualify the incident correctly: the deadlines run from the moment of awareness, not from the moment of the event.

Telemedicine

Telemedicine is the remote delivery of healthcare services, typically through digital technologies. Telemedicine includes a number of activities, including: Televisit: a remote medical consultation, often by videoconference. Teleconsultation: remote medical consultation or advice, synchronous or asynchronous, between doctors, other health professionals and patients. Telemonitoring: remote monitoring of a patient’s vital signs, typically through digital devices. Telecare: support and care services delivered remotely by health professionals to patients. Telesurgery: surgical procedures in which the surgeon or surgeons performing the operation are at a distance from the patient and control robotic devices remotely. Telerehabilitation: rehabilitation in which health professionals may be at a distance from the patient. Telemedicine is a key resource for improving the quality of care and the care experience, for both patients and healthcare professionals.

Telemonitoring

Telemonitoring is a telemedicine service that allows clinical parameters and vital signs (for example blood pressure, oxygen saturation, blood glucose, heart rate) to be monitored remotely through connected devices. The data collected are transmitted to healthcare professionals or monitoring centres, who can assess trends, detect early signs of deterioration and intervene promptly. Telemonitoring is particularly useful in managing chronic conditions, in post-discharge follow-up and in community-based care models.

Treatment Adherence

Treatment adherence is the extent to which a person’s behaviour – taking medication, following a diet or making lifestyle changes – matches the instructions and recommendations of their doctor. The higher the treatment adherence, the greater the chances of achieving the expected results of the therapy and preventing or reducing possible complications. Finally, adequate treatment adherence can help reduce healthcare costs for whoever typically bears them: the patient, the health system and/or an insurer.

Questions about other terms?

Our team is available to explore any technological or regulatory aspect in more depth.

Contact us now

Talk to us

Tell us how care is organised in your area: we'll prepare a demo on your own pathways, not on a textbook case.

Healthcare Glossary | Easy Health